Abbott10-Q: Debt refinancingApr 29, 2026

Abbott repays $1.4B of debt in Q1 2026 following Exact Sciences acquisition

What happened

After acquiring Exact Sciences, Abbott assumed $2.8B in debt and immediately repaid half ($1.4B), signaling a focus on deleveraging and rapid financial integration. This large-scale debt management activity creates complexity for treasury and finance teams responsible for integrating and managing new liabilities.

Source

SEC EDGARApr 29, 2026

Quarterly report (Form 10-Q)

Abbott 10-Q

Filing excerpt

As part of the acquisition, Abbott assumed approximately $2.8 billion of Exact Sciences’ debt, of which $1.4 billion was repaid in March 2026.

sec.gov/Archives/edgar/data/1800/000162828026028357/abt-20260331.htmRead the full source

Other signals in this filing (4)

RestructuringAbbott completed its acquisition of Exact Sciences on March 23, 2026, triggering integration efforts.RestructuringApr 29, 2026
Acquisition completedAbbott completes acquisition of Exact Sciences on March 23, 2026, and begins integration.Acquisition completedApr 29, 2026
Compliance burdenAbbott faces new compliance burden from OECD's 15% global minimum tax rulesCompliance burdenApr 29, 2026
Software implementationAbbott is assessing the impact of the OECD's 15% global minimum tax (Pillar 2), likely requiring system changes.Software implementationApr 29, 2026

Extracted by Autobound

From the Signal API record

Signal: 10-Q: Debt refinancing

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end: 03/31
Filed: Apr 29, 2026

More 10-Q signals at other companies

SEC 10-QMillerKnoll, Inc.Jeffrey M. Stutz appointed Interim Chief Executive Officer.SEC 10-QSep 28, 2026
SEC 10-QCID HoldCo, Inc.Disclosed material weaknesses in financial reporting due to insufficient accounting staff and controls.SEC 10-QSep 25, 2026
SEC 10-QScholastic CorporationCore school channels decline with fewer book fairs and lower club participation.SEC 10-QSep 25, 2026

The full record

From the Signal API record

Numbers

Dollar figure: $1.4B (Amount of debt repaid in March 2026 that was assumed from the Exact Sciences acquisition.)

Details

CIK: 1800
Accession number: 0001628280-26-028357
Timeframe: Current quarter
Filing year: 2026
Fiscal year: 0
Why it matters: Capital available or pressure
Signal category: Financial

Topics and mentions

Competitors

Exact Sciences

Extraction

Confidence: High
Relevance: 90%
Sentiment: Neutral
Detected: May 5, 2026
signal_type: sec-10q
signal_subtype: debtRefinancing

Use this data

Get every 10-Q signal for Abbott and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”
MCP setup guide
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/0026c9c7-287a-4657-840b-52ac0013fb4c returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "0026c9c7-287a-4657-840b-52ac0013fb4c",
  "signal_type": "sec-10q",
  "signal_subtype": "debtRefinancing",
  "detected_at": "2026-05-05T08:48:22.708+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "detail": "After acquiring Exact Sciences, Abbott assumed $2.8B in debt and immediately repaid half ($1.4B), signaling a focus on deleveraging and rapid financial integration. This large-scale debt management activity creates complexity for treasury and finance teams responsible for integrating and managing new liabilities.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "Amount of debt repaid in March 2026 that was assumed from the Exact Sciences acquisition.",
      "dollar_millions": 1400
    },
    "summary": "Abbott repays $1.4B of debt in Q1 2026 following Exact Sciences acquisition",
    "excerpts": "As part of the acquisition, Abbott assumed approximately $2.8 billion of Exact Sciences’ debt, of which $1.4 billion was repaid in March 2026.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/abt-20260331.htm",
    "filing_date": "2026-04-29",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Capital available or pressure",
    "signal_category": "financial",
    "competitors_mentioned": [
      "Exact Sciences"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/0026c9c7-287a-4657-840b-52ac0013fb4c \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbott.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.